67 related articles for article (PubMed ID: 21712131)
1. Re: Liu et al.: Association between manganese superoxide dismutase gene polymorphism and risk of prostate cancer: a meta-analysis (Urology 2009;74:884).
Wei B; Xu Z
Urology; 2011 Jul; 78(1):235; author reply 235-6. PubMed ID: 21712131
[No Abstract] [Full Text] [Related]
2. Association between manganese superoxide dismutase gene polymorphism and risk of prostate cancer: a meta-analysis.
Liwei L; Chunyu L; Ruifa H
Urology; 2009 Oct; 74(4):884-8. PubMed ID: 19647296
[TBL] [Abstract][Full Text] [Related]
3. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
[TBL] [Abstract][Full Text] [Related]
4. Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study.
Ergen HA; Narter F; Timirci O; Isbir T
Anticancer Res; 2007; 27(2):1227-30. PubMed ID: 17465268
[TBL] [Abstract][Full Text] [Related]
5. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - A meta-analysis.
Wang S; Wang F; Shi X; Dai J; Peng Y; Guo X; Wang X; Shen H; Hu Z
Eur J Cancer; 2009 Nov; 45(16):2874-81. PubMed ID: 19467856
[TBL] [Abstract][Full Text] [Related]
6. Re: Jiang et al.: Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk (Urology 2010;76:765).
Sergentanis TN; Economopoulos KP
Urology; 2011 Jan; 77(1):259-60. PubMed ID: 21195855
[No Abstract] [Full Text] [Related]
7. XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis.
Geng J; Zhang Q; Zhu C; Wang J; Chen L
Urology; 2009 Sep; 74(3):648-53. PubMed ID: 19428062
[TBL] [Abstract][Full Text] [Related]
8. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review.
Bag A; Bag N
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3298-305. PubMed ID: 19064542
[TBL] [Abstract][Full Text] [Related]
9. Re: Li et al.: XRCC3 T241M Polymorphism and bladder cancer risk: a meta-analysis (Urology 2011;77:e511-e515).
Wei B; Xu Z
Urology; 2011 Jul; 78(1):237-8. PubMed ID: 21712134
[No Abstract] [Full Text] [Related]
10. Association of a new intronic polymorphism of the SOD2 gene (G1677T) with cancer.
Hernandez-Saavedra D; McCord JM
Cell Biochem Funct; 2009 Jun; 27(4):223-7. PubMed ID: 19405048
[TBL] [Abstract][Full Text] [Related]
11. Correspondence re: J.L. Stanford et al., Polymorphic receptor in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57: 1194-1198, 1997.
Yasui T
Cancer Res; 2000 Jan; 60(2):499. PubMed ID: 10667606
[No Abstract] [Full Text] [Related]
12. Association between manganese superoxide dismutase polymorphism and risk of lung cancer.
Zejnilovic J; Akev N; Yilmaz H; Isbir T
Cancer Genet Cytogenet; 2009 Feb; 189(1):1-4. PubMed ID: 19167605
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
[TBL] [Abstract][Full Text] [Related]
14. Manganese superoxide dismutase polymorphism and risk of skin cancer (United States).
Han J; Colditz GA; Hunter DJ
Cancer Causes Control; 2007 Feb; 18(1):79-89. PubMed ID: 17186424
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients.
Ezzikouri S; El Feydi AE; Chafik A; Afifi R; El Kihal L; Benazzouz M; Hassar M; Pineau P; Benjelloun S
Mutat Res; 2008 Jan; 649(1-2):1-6. PubMed ID: 18023606
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
[TBL] [Abstract][Full Text] [Related]
17. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
Shaik AP; Jamil K; Das P
Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
[TBL] [Abstract][Full Text] [Related]
18. An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.
Mo Z; Gao Y; Cao Y; Gao F; Jian L
Prostate; 2009 May; 69(6):662-88. PubMed ID: 19143011
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of GSTP1 and related genes and prostate cancer risk.
Beer TM; Evans AJ; Hough KM; Lowe BA; McWilliams JE; Henner WD
Prostate Cancer Prostatic Dis; 2002; 5(1):22-7. PubMed ID: 15195126
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Elhan AH; Karakaya AE
Cell Biochem Funct; 2005; 23(1):73-6. PubMed ID: 15386537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
